Fidelity Investments’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.45K Buy
1,813
+1,262
+229% +$2.46K ﹤0.01% 5194
2026
Q2
$1.15K Buy
+551
New +$1.08K ﹤0.01% 5219
2026
Q1
– Sell
-10
Closed -$24 – 5528
2025
Q4
$24 Buy
+10
New +$19 ﹤0.01% 5346
2024
Q2
– Hold
0
– -$1 – 5569
2024
Q1
– Sell
-3
Closed -$21 – 5334
2023
Q4
$22 Buy
+3
New +$26 ﹤0.01% 5190
2022
Q4
– Sell
-27
Closed -$1.99K – 5522
2022
Q3
$1.99K Buy
+27
New +$5.72K ﹤0.01% 4572
2021
Q1
– Hold
0
– – – 4388
2020
Q4
– Hold
0
– – – 4172
2018
Q4
– Hold
0
– – – 3966
2018
Q3
– Hold
0
– – – 3721

Other funds holding PALI

Fidelity Investments's PALI Position: Q3 2026 in Review

Fidelity Investments increased its Palisade Bio (PALI) stake by 229% in Q3 2026, buying an estimated $2.46K and bringing the position to 1,813 shares worth $2.45K. The position accounts for ﹤0.01% of the portfolio, ranked #5194.

Fidelity Investments first reported a position in PALI in Q3 2022 and has held it in 5 quarters since. 116 funds tracked by Wall St. Rank hold PALI as of Q3 2026.

  • Fidelity Investments held 1,813 shares of Palisade Bio worth $2.45K as of Q3 2026.
  • Fidelity Investments bought 1,262 Palisade Bio shares in Q3 2026, an estimated $2.46K.
  • Palisade Bio made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #5194 holding.
  • Fidelity Investments first reported a position in Palisade Bio in Q3 2022 and has held it in 5 quarters since.
  • 116 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.